MYADM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.577800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.733400E-01
Normal-vs-Stage2
5.380800E-01
Normal-vs-Stage3
8.717200E-01
Normal-vs-Stage4
1.116160E-01
Stage1-vs-Stage2
4.078600E-01
Stage1-vs-Stage3
8.332800E-01
Stage1-vs-Stage4
9.768500E-02
Stage2-vs-Stage3
6.133400E-01
Stage2-vs-Stage4
1.270640E-01
Stage3-vs-Stage4
6.617800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.589400E-01
Normal-vs-AfricanAmerican
7.430600E-01
Normal-vs-Asian
5.878800E-01
Caucasian-vs-AfricanAmerican
8.561800E-01
Caucasian-vs-Asian
9.292200E-01
AfricanAmerican-vs-Asian
8.513800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.130200E-01
Normal-vs-Female
4.782200E-01
Male-vs-Female
5.747800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.815800E-01
Normal-vs-Age(41-60Yrs)
2.963400E-01
Normal-vs-Age(61-80Yrs)
6.620400E-01
Normal-vs-Age(81-100Yrs)
9.902000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.810000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.396800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.612000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.954100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.842300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.027400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.695200E-01
Normal-vs-Daily Drinker
9.983800E-01
Normal-vs-Weekly Drinker
3.657800E-01
Normal-vs-Occasional Drinker
6.036000E-01
Normal-vs-Social Drinker
6.261400E-01
Non Drinker-vs-Daily Drinker
9.244800E-01
Non Drinker-vs-Weekly Drinker
5.348400E-02
Non Drinker-vs-Occasional Drinker
3.412600E-01
Non Drinker-vs-Social Drinker
2.730000E-01
Daily Drinker-vs-Weekly Drinker
4.406000E-02
Daily Drinker-vs-Occasional Drinker
3.128400E-01
Daily Drinker-vs-Social Drinker
2.691600E-01
Weekly Drinker-vs-Occasional Drinker
2.026200E-01
Weekly Drinker-vs-Social Drinker
4.684800E-01
Occasional Drinker-vs-Social Drinker
7.296800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.816000E-01
Normal-vs-Grade 2
1.220600E-01
Normal-vs-Grade 3
2.012400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.388640E-01
Grade 1-vs-Grade 3
9.697600E-01
Grade 1-vs-Grade 4
2.816000E-01
Grade 2-vs-Grade 3
6.246000E-02
Grade 2-vs-Grade 4
1.220600E-01
Grade 3-vs-Grade 4
2.012400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.368000E-01
Normal-vs-NonDiabetic
6.172600E-01
Diabetic-vs-NonDiabetic
7.287800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.714400E-01
Normal-vs-NoPancreatitis
6.239000E-01
Pancreatitis-vs-NoPancreatitis
7.388000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.821200E-01
Normal-vs-N1
5.187400E-01
N0-vs-N1
5.431600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.930200E-01
Normal-vs-TP53-NonMutant
6.158600E-01
TP53-Mutant-vs-TP53-NonMutant
2.470600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
